These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


78 related items for PubMed ID: 25565308

  • 1. Genetic homogeneity but IgG subclass-dependent clinical variability of alloimmune membranous nephropathy with anti-neutral endopeptidase antibodies.
    Vivarelli M, Emma F, Pellé T, Gerken C, Pedicelli S, Diomedi-Camassei F, Klaus G, Waldegger S, Ronco P, Debiec H.
    Kidney Int; 2015 Mar; 87(3):602-9. PubMed ID: 25565308
    [Abstract] [Full Text] [Related]

  • 2. Role of truncating mutations in MME gene in fetomaternal alloimmunisation and antenatal glomerulopathies.
    Debiec H, Nauta J, Coulet F, van der Burg M, Guigonis V, Schurmans T, de Heer E, Soubrier F, Janssen F, Ronco P.
    Lancet; 2015 Mar; 364(9441):1252-9. PubMed ID: 15464186
    [Abstract] [Full Text] [Related]

  • 3. Lessons from a rare disease: IgG subclass and disease severity in alloimmune antenatal membranous nephropathy.
    Beck LH.
    Kidney Int; 2015 Mar; 87(3):494-7. PubMed ID: 25723631
    [Abstract] [Full Text] [Related]

  • 4. Neonatal disease in neutral endopeptidase alloimmunization: lessons for immunological monitoring.
    Nortier JL, Debiec H, Tournay Y, Mougenot B, Nöel JC, Deschodt-Lanckman MM, Janssen F, Ronco P.
    Pediatr Nephrol; 2006 Oct; 21(10):1399-405. PubMed ID: 16900384
    [Abstract] [Full Text] [Related]

  • 5. Fetomaternal alloimmunization with antenatal glomerulopathies.
    Debiec H, Ronco P.
    Ann N Y Acad Sci; 2007 Sep; 1110():559-66. PubMed ID: 17911472
    [Abstract] [Full Text] [Related]

  • 6. [Anti-CD10 fetomaternal alloimmunisation].
    Ronco P, Debiec H, Guigonis V.
    Med Sci (Paris); 2009 Jan; 25(1):64-8. PubMed ID: 19154696
    [Abstract] [Full Text] [Related]

  • 7. Membranous nephropathy: recent travels and new roads ahead.
    Beck LH, Salant DJ.
    Kidney Int; 2010 May; 77(9):765-70. PubMed ID: 20182413
    [Abstract] [Full Text] [Related]

  • 8. Antenatal membranous glomerulonephritis due to anti-neutral endopeptidase antibodies.
    Debiec H, Guigonis V, Mougenot B, Decobert F, Haymann JP, Bensman A, Deschênes G, Ronco PM.
    N Engl J Med; 2002 Jun 27; 346(26):2053-60. PubMed ID: 12087141
    [No Abstract] [Full Text] [Related]

  • 9. [Anti-CD 10 maternal-fetal allo-immunisation].
    Ronco P, Debiec H.
    Bull Acad Natl Med; 2012 Nov 27; 196(8):1613-22; discussion 1622-3. PubMed ID: 24313016
    [Abstract] [Full Text] [Related]

  • 10. [Anti-NEP and anti-PLA2R antibodies in membranous nephropathy: an update].
    Pozdzik AA, Debiec H, I Brochériou, Husson C, Rorive S, Broeders N, Le Moine A, Ronco P, Nortier J.
    Rev Med Brux; 2015 Nov 27; 36(3):166-71. PubMed ID: 26372979
    [Abstract] [Full Text] [Related]

  • 11. Molecular pathomechanisms of membranous nephropathy: from Heymann nephritis to alloimmunization.
    Ronco P, Debiec H.
    J Am Soc Nephrol; 2005 May 27; 16(5):1205-13. PubMed ID: 15800120
    [Abstract] [Full Text] [Related]

  • 12. [Extra-membranous glomerulonephritis: from the experimental model to the human pathology of new-born and adult].
    Ronco P.
    Bull Mem Acad R Med Belg; 2008 May 27; 163(3-4):179-86; discussion 186-8. PubMed ID: 19025206
    [Abstract] [Full Text] [Related]

  • 13. New insights into the pathogenesis of membranous glomerulonephritis.
    Ronco P, Debiec H.
    Curr Opin Nephrol Hypertens; 2006 May 27; 15(3):258-63. PubMed ID: 16609292
    [Abstract] [Full Text] [Related]

  • 14. [Extra-membranous glomerulonephritis: report of a family and new physiopathological concepts].
    Debiec H, Guigonis V, Mougenot B, Haymann JP, Bensman A, Deschênes G, Ronco P.
    Bull Acad Natl Med; 2003 May 27; 187(5):921-32; discussion 932-4. PubMed ID: 14979057
    [Abstract] [Full Text] [Related]

  • 15. [The involvement of neprilysin in the pathogenesis of glomerulopathies].
    Kubiak-Wlekły A, Niemir ZI.
    Pol Merkur Lekarski; 2009 Sep 27; 27(159):239-41. PubMed ID: 19827739
    [Abstract] [Full Text] [Related]

  • 16. Anti-neutral endopeptidase, natriuretic peptides disarrangement, and proteinuria onset in membranous nephropathy.
    Hu P, Xuan Q, Hu B, Lu L, Qin YH.
    Mol Biol Rep; 2013 Apr 27; 40(4):2963-7. PubMed ID: 23271116
    [Abstract] [Full Text] [Related]

  • 17. [Idiopathic and secondary membranous nephropathies].
    Ronco P, Debiec H.
    Presse Med; 2012 Mar 27; 41(3 Pt 1):290-7. PubMed ID: 22208961
    [Abstract] [Full Text] [Related]

  • 18. Distribution of glomerular IgG subclass deposits in patients with membranous nephropathy and anti-U1 ribonucleoprotein antibody.
    Omokawa A, Komatsuda A, Nara M, Fujiwara S, Sato R, Togashi M, Okuyama S, Sawada K, Wakui H.
    Nephrol Dial Transplant; 2012 May 27; 27(5):1937-41. PubMed ID: 21968014
    [Abstract] [Full Text] [Related]

  • 19. Advances in membranous nephropathy: success stories of a long journey.
    Ronco P, Debiec H.
    Clin Exp Pharmacol Physiol; 2011 Jul 27; 38(7):460-6. PubMed ID: 21388432
    [Abstract] [Full Text] [Related]

  • 20. A podocyte view of membranous nephropathy: from Heymann nephritis to the childhood human disease.
    Ronco P, Debiec H.
    Pflugers Arch; 2017 Aug 27; 469(7-8):997-1005. PubMed ID: 28597189
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 4.